Interventional Treatment VTE: Radiologic Approach

Similar documents
Surgical approach for DVT. Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine

Pharmaco-mechanical techniques stand alone procedures? Peter Neglén, MD, PhD SP Vascular Center Limassol Cyprus

Aggressive endovascular management of ilio-femoral DVT. thrombotic syndrome. is the key in preventing post

THERE IS NO ROLE FOR SURGICAL THERAPY FOR DVT

Venous interventions in DVT

Technique de recanalisation: mon expérience avec Aspirex

Not all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Case 1:

Methods of Thrombus Fragmentation & Extraction. Methods of Thrombus Extraction

4/23/2009. September 15, 2008

Percutaneous Mechanical Thrombectomy for Acute Iliofemoral DVT with the Aspirex Catheter: The Dijon Experience

Iliofemoral DVT: Miminizing Post-Thrombotic Syndrome

Treatment of Chronic DVT with EKOS: Reproducing ACCESS PTS Data in Every Day Clinical Practice

Optimal Utilization of Thrombolytics

Venous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.

NOTE: Deep Vein Thrombosis (DVT) Risk Factors

Should We Be More Aggressive in the Treatment of Acute DVT?

Michael Meuse, M.D. Vascular and Interventional Radiology

Complex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism

Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related. Iliocaval Thrombosis

Chronic Iliocaval Venous Occlusive Disease

Treatment of acute thrombosis of axillo-subclavian vein

The hallmark of percutaneous thrombus management

DEEP VENOUS THROMBOSIS A PRACTICAL APPROACH TO IMPROVING CLINICAL OUTCOMES

Thrombolysis in Critical Limb Ischemia Frank J. Arena, MD, FACC, FSCAI

How long to continue anticoagulation after DVT?

VIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction

The Evidence Base for Treating Acute DVT

Intervention for Deep Venous Thrombosis and Pulmonary Embolus

Improved clinical outcomes Evidence on venous thrombectomy followed by stenting

Expanding Horizons: AngioVac Suction Thrombectomy at UTHealth

Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients

EKOS. Interventional Vascular 3 February, Imagine where we can go.

Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. J Vasc Surg. 2012;55:

Acoustic Pulse Thrombolysis Treatment

Successful recanalisation of venous thrombotic occlusions with Aspirex mechanical thrombectomy. Michael K. W. Lichtenberg

The hallmark of percutaneous thrombus management

Proper Diagnosis of Venous Thromboembolism (VTE)

BC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8

Surgical Options in Thrombectomy for Non-Surgeons

VERNACULAR Trial & Clinical Experience with the VENOVO Venous Stent

Venous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC

Lysis-Assisted Balloon (LAB) Thrombectomy

Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT Trial)

Canadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS

Techniques for thrombus removal in acute DVT Benefits of an Endovascular Approach for Rapid Flow Restoration in DVT

Mechanical thrombectomy in acute thrombosis of dialysis fistulas: a multi-center study

Improved clinical outcomes Evidence on venous mechanical thrombectomy followed by stenting

Straub Endovascular System &

ENDOVASCULAR THERAPIES FOR ACUTE STROKE

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

Jordan M. Garrison, MD FACS, FASMBS

Catheter direct thrombolysis: Role of actilyse in treatment of acute deep venous thrombosis

Clinical results of venous stents. Michael K. W. Lichtenberg MD, FESC

Aspirex for Upper and Lower Extremity DVT

Treatment of May-Thurner Syndrome with Catheter-Guided Local Thrombolysis and Stent Insertion

Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Copy Here. The Easy One.. What is the Role of Thrombus Removal in Acute Proximal DVT after ATTRACT? Deep Venous Thrombosis Spectrum

J Jpn Coll Angiol, 2009, 49:

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information

Ileo Femoral DVT Review and Update

How to best approach chronic venous occlusions?

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas

Treatment of Axillosubclavian Vein Thrombosis: A Novel Technique for Rapid Removal of Clot Using Low-Dose Thrombolysis

Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

What is New in Acute Pulmonary Embolism? Interventional Treatment. Prof. Nils Kucher University Hospital Bern Switzerland

- Our patients with iliofemoral DVT - Effective thrombus removal with purely mechanical thrombectomy can lead to better outcomes

Rescue procedures in acute visceral ischemia

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

PEARL Registry Update Overview Venous Arterial AV Access

Emerging Tools for Lytic-Free, Single-Session Treatment of Venous Thromboembolic Disease

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Mechanical Thrombectomy Devices. Thomas M. Vesely, MD Vascular Access Services, LLC Saint Louis, Missouri

The Conservative and Active Management of Post Thrombotic Syndrome

Starting with deep venous treatment

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

The Ideal Venous Stent and Early Results from Venous Stent Trials PNEC, Seattle

Use of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group

The evidence for venous interventions is evolving- many patients do actually benefit. Nils Kucher University Hospital Bern Switzerland

What is the impact of Superficial Vein Thrombosis?

DVT - initial management NSCCG

Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS

PEARL REGISTRY Post Market Registry

SAMPLE CHAPTERS UNESCO-EOLSS MANAGEMENT OF SUBCLAVIAN VEIN THROMBOSIS KNOWN AS PAGET-SCHROETTER SYNDROME

Deep Vein Thrombosis

Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006)

Prevention of VTE Sequelae: Post-thrombotic Syndrome and Chronic Thromboembolic Pulmonary Hypertension

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Catheter-Directed Thrombolysis for Acute Limb Ischemia. Hwan Jun Jae MD Seoul National University Hospital Seoul, Korea

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

Ultrasound-assisted catheter-directed thrombolysis: Does it really work? The BERNUTIFUL trial

WHO YOU GONNA CALL? CLOT-BUSTERS!

A Brief Guide Treatment and Prevention

Management of Post-Thrombotic Syndrome

Transcription:

Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea

Introduction Incidence High incidence: 250,000-1,000,000/year in US In Korea: increased in incidence Aging society Malignancy High detection rate Risk Factors DVT of lower extremities Old age, Debilitating state, Malignancy, Major surgery Hypercoagulability, Pregnancy, Contraceptive, Hormonal therapy Antiphospholipid antibody syndrome, Inflammatory bowel disease, SLE, Varicose vein, Previous DVT, Central venous catheter

Introduction Post-thrombosis syndrome Pain, swelling, skin discoloration, heaviness, venous claudication & ulceration Iliofemoral DVT High incidence & worse prognosis Rarely recanalize via endogenous processes Persistent outflow obstruction-high venous pressure Higher incidence of recurrent DVT than infrainguinal thrombosis Damaged venous valve & obstruction Rapid progression in recurrent thrombosis Incidence: 1 yr - 17.3%, 8 yr 29% Severity of DVT & Occ. of PTS: low correlation Worse life quality Complications of DVT Br J Radiol 2009;82:198, Arch Intern Med 2002;62:1144, Arch Intern Med 2004;164:17, J Vasc Surg 2009;49:704

Introduction Complications of DVT Pulmonary thromboembolism Majority of DVT Pts No or weak relation with DVT extent & clot amount Life threatening Br J Radiol 2009;82:198, Arch Intern Med 2002;62:1144, Arch Intern Med 2004;164:17, J Vasc Surg 2009;49:704

Dx D-dimer Screening Introduction US Screening Compression & Color Doppler Imgaging Venography CT & MR venography Pelvis & Abdomen: Extent Adequacy of outflow DVT of lower extremities

Introduction Venous valve Rest Systolic Diastolic

Introduction Pathology after DVT 3 days 1 wk 2 wks 4 wks Ann Surg 1987;205:312

Introduction Chronic change: 4 wks after Tx Surgical Thrombectomy Thrombolysis J Vasc Surg 2000;31:1193-205

Introduction Vascular change: DVT 10 years earlier No venous obstruction

Indications Acute thrombosis < 10 days Response Favorable prognosis Chronic lesions Poor response Sometimes amenable An experimental study Residual thrombus Organized & recanalized thrombus at 4 wks Re-endothelialization at 4 wks Combined reflux Incompetent valve Combined lesions Stenosis Obstruction Systemic disease Vasc Surg 2000;31:1193

Treatment Goals Prevention of PE Prevention of DVT propagation Provision of early symptom relief Prevention of PTS DVT of lower extremities Tx Anticoagulant Conventional Tx-systemic Catheter-directed thrombolysis Mechanical thrombectomy Combined JVIR 2006;17:613

Treatment Anticoagulation Post-thrombosis syndrome Fails to prevent PTS in significant proportion Life quality Significant disability QOL impairment Socioeconomic Condition Surgery: contemporary tech. AVF Improved patency Less venous pressure Less edema & PTS Conventional & Surgical Tx Eur J Vasc Endovasc Surg 2007;33:351, JVIR 2006;17:613

Treatment Catheter-directed thrombolysis Decreases incidence of PTS Early thrombosis removal Normal valvular function 72% vs 12%(anticoagulation) Interventional Tx Improved QOL Faster Sx relief than anticoagulation Hours to days PE & PE related death: 0.9% & 0.1% Radiology 1999:211:39, JVIR 2005;16:815, J Vasc Surg 2000;32:130, JVIR 2006;17:613

Treatment Catheter-directed thrombolysis Thrombolysis with UK + Stenting 1 st Patency, 1yr & 2yr: 95% 2 nd Patency, 1yr & 2yr: 100% Disadvantage High dose of thrombolytic agent Prolonged procedure time: Esp. chronic Bleeding Mostly vascular access Major bleeding 8-11%, Intracranial bleeding 0.2% Possible lack of long term benefits Interventional Tx Radiology 1999:211:39, J Vasc Surg 2009;49:704, JVIR 2005;16:815

Treatment Interventional Tx Group 1: Anticoagulation, Group 2: Thrombolysis Ann Surg 2001;233:752

Treatment Mechanical thrombectomy Embolic complications Often inadequate Hemolytic complications anemia and renal dysfunction Relative short procedure time Interventional Tx Eur J Vasc Endovasc Surg 2007;33:351 JVIR 2001; 12:147 164

Amplatz device Treatment Rotational blender-like impeller Mechanical thrombectomy 100,000 to 150,000 rpm Aspirate & re-circulate macerated thrombus Results Removal of thrombus: 75-83% 6 month patency: 77% Procedural related desaturation No clinically significant PE Eur J Vasc Endovasc Surg 2007;33:351

Treatment Arrow-Trerotola device Rotational design 4 helically arranged nitinol wires 3000 rpm Re-circulates macerates thrombus Mechanical thrombectomy Thrombolytic therapy & angioplasty with stents Technical & clinical success: 100% 16-month: 92% Valve & intimal damage No reports Eur J Vasc Endovasc Surg 2007;33:351

Treatment AngioJet device High-velocity saline jet (350-450 km/hr) Zone of negative pressure around the catheter tip Advantages Less vessel trauma Mechanical thrombectomy Ability to aspirate thrombus Results Without preprocedural thrombolytic therapy ½ Pts: removal of 50% thrombus & 77% of patency Another study 65% of Pts: complete removal Eur J Vasc Endovasc Surg 2007;33:351

Treatment Trellis catheter Hybrid catheter Isolates thrombosed vein segment between two occluding balloons Thrombolytics infusion between occluding balloons Dispersion wire into the catheter spiral configuration 1500 rpm 15-20 min: thrombus aspiration Advantages Mechanical & pharmacologic therapies Infusate aspiration: Avoid systemic thrombolysis Rapidity Prevent PE by occluding balloon Results Procedure time: 91 min Complete lysis(>95%): 14% 1st patency in 2 days: 86% Mechanical thrombectomy Eur J Vasc Endovasc Surg 2007;33:351, JVIR 2007;18:715

Treatment Ultrasound-accelerated Thrombolysis US + Catheter-directed thrombolytics Mechanical thrombectomy Infusion catheter with ultrasound transducers Clot fibrin fragmentation Results Complete lysis:70% Overall lysis: 91% Infusion time: 22.0 hrs Eur J Vasc Endovasc Surg 2007;33:351, JVIR 2008; 19:521

Treatment Korean style Thrombolysis with UK 30,000-120,000 U/Hr for 4 hr-overnight Thromboaspiration with 8-9F vascular sheath Contraindication of thrombolysis Refused thrombolysis Occasionally combined balloon maceration Mostly within 2 hrs Blood loss Incomplete removal of thrombus Combination Thrombolysis with thromboaspiration Common in Korea Temporary IVC filter placement Most cases Rethrombosis Intervention US or CT follow-up